Both are FDA-approved with overlapping safety profiles, and the shared warnings (thyroid, pancreatitis, gallbladder) apply equally to each
doi:10.1016/j.ophtha.2011.09.005
More serious but rare adverse effects include pancreatitis, gallbladder disease, hypoglycemia (when used with insulin or sulfonylureas), acute kidney injury (particularly with dehydration), and hypersensitivity reactions including anaphylaxis
Generally, major insurers like UnitedHealthcare, Cigna, and Aetna, among others, provide coverage for weight loss medication prescribed for documented medical obesity
My Clinical Perspective Epitalons appeal lies in its elegant concept: rather than replacing melatonin, support the bodys own production